Logo Lanfrica

Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs

Type de record:

paper
Créateur:
CarSarElsLis
Éditeur:
Pub
Hôte:

Licenses

http://creativecommons.org/licenses/by/4.0/

Similaires

Novel Plasmodium falciparum K13 Gene Polymorphisms from Kisii County, Kenya during an era of Artemisinin-Based Combination Therapies (ACTs) deployment

Abstract Background Currently, Chemotherapy stands out as the major malaria intervention

Artemisinin Resistance–Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015

Emerging artemisinin resistance is a threat to global malaria control. Mutations in the Plasmodium

Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015

International audience One of the fundamental steps toward malaria control is the use

Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area

International audience Background: Malaria reduction and future elimination in China

Plasmodium falciparum Kelch13 polymorphisms identified after treatment failure with artemisinin- based combination therapy in Niger

Abstract Background: Artemisinin-based combination therapy (ACT) is the most effective t

Genetic diversity of Plasmodium falciparum and genetic profile after artemisinin-based combination therapy (ACTs) deployment in Cameroon for the management of uncomplicated malaria in Children

Abstract Background Plasmodium falciparum is the number one cause of malaria morbidity and